Inhibition of TLR4 shifts the microglial polarization from M1 to M2 and protects neuronal cells against the cytotoxicity of activated BV2 microglial cells via the downregulation of MyD88/NF-κB and NLRP3 signaling in AD. The gene discussed is NFKB1; the disease is Alzheimer disease.